Markets
NHS

Wednesday 12/23 Insider Buying Report: NHS, CAMB

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At Neuberger High Yield Strategies Fund ( NHS ), a filing with the SEC revealed that on Monday, Bradley Tank bought 28,000 shares of NHS, at a cost of $9.36 each, for a total investment of $262,083. Tank was up about 8.9% on the purchase at the high point of today's trading session, with NHS trading as high as $10.19 at last check today. Neuberger High Yield Strategies Fund is trading up about 1% on the day Wednesday. Before this latest buy, Tank made one other purchase in the past twelve months, buying $152,978 shares at a cost of $11.95 each.

And at Cambridge Capital Acquisition Corp ( CAMB ), there was insider buying on Monday, by CEO Benjamin Gordon who purchased 25,000 shares for a cost of $10.05 each, for a trade totaling $251,250. Before this latest buy, Gordon purchased CAMB at 6 other times during the past year, for a total investment of $201,698 at an average of $10.00 per share. Cambridge Capital Acquisition Corp is trading up about 1% on the day Wednesday. So far Gordon is in the green, up about 0.6% on their purchase based on today's trading high of $10.11.

VIDEO: Wednesday 12/23 Insider Buying Report: NHS, CAMB

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NHS

Other Topics

Investing

Latest Markets Videos